SEC Tracker
Get the app

Cerus CERS

Cerus FY 2022: revenue $188.3M, up 18%; diluted EPS −$0.24

Form
10-K
Filed
Period
Importance
Notable
Document
10-K

Key figures from this report

These are the numbers Cerus reported for the year ended Dec 31, 2022, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Revenue$188.3M+18% from $159.5M in FY 202110-K income statement, on EDGAR
  2. Net income−$42.8MAgainst −$54.4M in FY 202110-K income statement, on EDGAR
  3. Diluted EPS−$0.24Against −$0.32 in FY 202110-K income statement, on EDGAR
  4. Cash and cash equivalents$35.6M−27% from $48.8M in FY 2021Cash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
  5. Cash from operations−$25.6MAgainst −$33.9M in FY 202110-K cash flow statement, on EDGAR

Every year in the financial tables

View on EDGAR

Open in the app

Get an email when Cerus files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. SANUWAVE Health SNWV public float $233M, Jun 30, 2025
  2. Electromed ELMD public float $224M, Dec 31, 2025
  3. Tactile Systems Technology TCMD public float $223M, Jun 30, 2025
  4. Orasure Technologies OSUR public float $218M, Jun 30, 2025
  5. Heartflow HTFL